Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries Release Date: Partner: AMFROM | Quality Improvement | Oncology | Benin, Congo, The Democratic Republic, Mali, Senegal, Togo | |
Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management Release Date: Partner: Beijing Guangda Precision Medicine Research Center | Quality Improvement | Inflammation & Immunology | China | |
Optimizing Antimicrobial Stewardship Program in Saudi Arabia Release Date: | Quality Improvement | Inflammation & Immunology | Saudi Arabia | |
Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with Isavuconazole Release Date: | Research | Inflammation & Immunology | Australia, Germany, Israel, Italy, Spain, Switzerland | |
PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer Release Date: | Education | Oncology | USA | |
Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026 Release Date: | Research | Vaccines | India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam | |
Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infection Release Date: | Education | Vaccines | Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine | |
Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era Release Date: | Research | Vaccines | Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of | |
The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE Release Date: | Research | Hospital | China, Hong Kong | |
COVID-19 Disease Burden on the High Risk Population Release Date: | Education | Vaccines | All | |
New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease Release Date: | Research | Inflammation & Immunology | USA |
Title | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism Release Date: | Education | Internal Medicine | Japan | |
Education and Support for Patients with Locally-Advanced or Metastatic Bladder Cancer Release Date: Partner: Merck KGaA, Darmstadt, Germany and EMD Serono | Education | Oncology | USA | |
Pre-clinical & Translational Research in Multiple Myeloma Release Date: | Research | Oncology | Canada, USA | |
Management of Patients with BRAF-mutant metastatic colorectal cancer Release Date: | Education | Oncology | Canada, USA | |
Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease Release Date: | Quality Improvement | Rare Disease | All | |
Promotion of Smoking Cessation Treatment in General Practice Release Date: | Education | Internal Medicine | Japan | |
2021 Growth Hormone Research (All countries except for the United States) Release Date: | Research | Rare Disease | All | |
Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain | Education | Internal Medicine | All | |
NSCLC Therapy Management for Optimal Outcomes Release Date: | Quality Improvement | Oncology | Andorra, Austria, Belgium, Canada, Denmark, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom | |
Clinical Research Capability Development Release Date: | Education | Internal Medicine | China | |
Educational Program to Increase Awareness and Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Release Date: | Education | Rare Disease | China | |
Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists and Allergists Release Date: | Education | Inflammation & Immunology | USA |